JENNIFER CROFT: Open Payments
NPI 1255930426 · ROSEVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 54 payments from 35 companies in 2025. Trend: 2023 $887 · 2024 $2,065 · 2025 $1,105
Food & beverage: $1,085Education: $20
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 4 | $89 |
| Incyte Corporation | 3 | $64 |
| Daiichi Sankyo Inc. | 3 | $59 |
| Janssen Biotech, Inc. | 3 | $57 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| Astellas Pharma US Inc | 3 | $52 |
| Eisai Inc. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| SOBI, INC | 2 | $39 |
Products named: JAKAFI, Lenvima, KEYTRUDA, Polivy, Doptelet, DANZITEN, TECVAYLI, Rubraca.
Industry payments across MI — which companies pay providers there.
